TELETRADER News
10/20, 6:34 AM (Source: TeleTrader)
more TeleTrader news

Moderna+13.90%

127.01
Chart for: Moderna

Moderna may apply for vaccine approval in Dec.

Moderna CEO Stephane Bancel said that the company may seek emergency approval for its coronavirus vaccine candidate in December.

The timeline is based on the assumption that the interim vaccine trials yield positive results in November, he revealed at the Wall Street Journal's Tech Live conference.

In late July, Moderna launched large-scale trials for its vaccine, which were expected to include 30,000 participants. The study has to discover 53 people that are symptomatic for the disease so the first interim analysis could be carried out. The emergency authorization could be sought if there are significantly fewer vaccinated people than unvaccinated people among the 53.

Breaking the News / MS